Šw‰ï”•\
Inatani M, Iwasaki K, Komori R, Arimura S, Takamura Y.
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
The 40th APAO Congress, Delhi, India April 3-6, 2025
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
The 40th APAO Congress, Delhi, India April 3-6, 2025
Takamura Y
Efficacy of Vitrectomy for Diabetic Macular Edema: One-Year Follow-Up Multi-Center Study in Japan
TOA 59th National Congress, Antalya, Turkey, Nov 19-25, 2025
Efficacy of Vitrectomy for Diabetic Macular Edema: One-Year Follow-Up Multi-Center Study in Japan
TOA 59th National Congress, Antalya, Turkey, Nov 19-25, 2025
TMatsumura T, Arimura S, Iwasaki K, Suzuki M, Takamura Y, Inatani M
Changes in ocular higher-order aberrations and corneal backward light scattering after instillation of brimonidine/brinzolamide versus�@brimonidine/timolol: a randomized, double-masked, crossover clinical trial
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
Changes in ocular higher-order aberrations and corneal backward light scattering after instillation of brimonidine/brinzolamide versus�@brimonidine/timolol: a randomized, double-masked, crossover clinical trial
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
Arimura S, Iwasaki K, Suzuki M, Inatani M
A Deep Learning Model for Detecting the Eyes Receiving Glaucoma Medications Using Anterior Segment Images
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
A Deep Learning Model for Detecting the Eyes Receiving Glaucoma Medications Using Anterior Segment Images
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
Iwasaki K, Arimura S, Inatani M
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
ARVO 2025, Salt Lake City, Utah, USA May 4-8, 2025
Inatani M, Kohama I, Chu A.
Surgical outcomes analyzed with AAO MIGS success criteria from a Japan postmarket surveillance of iStent inject® W combined with phacoemulsification
11th World Glaucoma Congress, Honolulu, Hawaii, USA, June 25-28, 2025
Surgical outcomes analyzed with AAO MIGS success criteria from a Japan postmarket surveillance of iStent inject® W combined with phacoemulsification
11th World Glaucoma Congress, Honolulu, Hawaii, USA, June 25-28, 2025
Iwasaki K, Arimura S, Inatani M
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
The 18th Joint Meeting of China-Japan-Korea Ophthalmologists, Hangzhou International Expo Center, Hangzhou, China Sep 6, 2025
Intraocular Pressure-Lowering Effect of Intraocular Lens Refixation in Patients with Elevated Intraocular Pressure Due to Intraocular Lens Subluxation
The 18th Joint Meeting of China-Japan-Korea Ophthalmologists, Hangzhou International Expo Center, Hangzhou, China Sep 6, 2025
Yamada Y, Takamura Y, Inatani M, J-CREST Group
Efficacy of Vitrectomy for Diabetic Macular Edema: One-Year Follow-Up Multi-Center Study in Japan
The 5th Asia Retina Congress, Taipei, Taiwan, Oct 25-26, 2025
Efficacy of Vitrectomy for Diabetic Macular Edema: One-Year Follow-Up Multi-Center Study in Japan
The 5th Asia Retina Congress, Taipei, Taiwan, Oct 25-26, 2025
Inatani M, Chan P, Choi W, Yip V, Rehn A, Chu A.
Postoperative Complications of iStent inject Combined with Phacoemulsification in Asian Eyes with Glaucoma: Findings From a Systematic Review and Meta-Analysis
The 41th APAO Congress, Hong Kong, China, Feb 5-8, 2026
Postoperative Complications of iStent inject Combined with Phacoemulsification in Asian Eyes with Glaucoma: Findings From a Systematic Review and Meta-Analysis
The 41th APAO Congress, Hong Kong, China, Feb 5-8, 2026
îà‘º�@‰À�O
“œ”A•aŠá�‡•¹�Ç Š³ŽÒƒtƒ@�[ƒXƒg‚ÉŠî‚Â�ŗǂ̎¡—Ã�í—ª‚ÌŠm—§‚ð‚ß‚´‚µ‚Ä
‘æ129‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@
—ߘa7”N4ŒŽ17-20“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
“œ”A•aŠá�‡•¹�Ç Š³ŽÒƒtƒ@�[ƒXƒg‚ÉŠî‚Â�ŗǂ̎¡—Ã�í—ª‚ÌŠm—§‚ð‚ß‚´‚µ‚Ä
‘æ129‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@
—ߘa7”N4ŒŽ17-20“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ˆî’J�@‘å
”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“(iStent‚ÆHydrus)
‘æ40‰ñJSCRSŠw�p‘�‰ï�@‹³ˆçƒZƒ~ƒi�[ ”’“à�áŽè�p‚ÆMIGS
—ߘa7”N6ŒŽ20-22“ú�@•Ÿ‰ª�‘�Û‰ï‹c�ê
”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“(iStent‚ÆHydrus)
‘æ40‰ñJSCRSŠw�p‘�‰ï�@‹³ˆçƒZƒ~ƒi�[ ”’“à�áŽè�p‚ÆMIGS
—ߘa7”N6ŒŽ20-22“ú�@•Ÿ‰ª�‘�Û‰ï‹c�ê
—L‘º�@�®Œå
�l�H’m”\‚É‚æ‚é‰ÂŽ‹‰»‚ÉŠî‚—Γà�á‚Ì’è‹`
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€1
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
�l�H’m”\‚É‚æ‚é‰ÂŽ‹‰»‚ÉŠî‚—Γà�á‚Ì’è‹`
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€1
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
Šâí•�@Œ’‘¾˜Y
—Ž‹û—Γà�á‚ɑ΂·‚éàh‰ßŽè�p‚ÌŒø‰Ê‚Ɖۑè
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€4
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
—Ž‹û—Γà�á‚ɑ΂·‚éàh‰ßŽè�p‚ÌŒø‰Ê‚Ɖۑè
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€4
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
îà‘º�@‰À�O
—ߘa‚Ì“œ”A•a–Ô–Œ�ǃŒ�[ƒU�[Ž¡—Ã�@�`–Ô–ŒƒŒ�[ƒU�[‚ð�Ä�l‚µ‚悤�`�@–ò•¨Ž¡—ÂƂ̕¹—p
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR�[ƒX�iƒIƒ“ƒfƒ}ƒ“ƒh�j
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
—ߘa‚Ì“œ”A•a–Ô–Œ�ǃŒ�[ƒU�[Ž¡—Ã�@�`–Ô–ŒƒŒ�[ƒU�[‚ð�Ä�l‚µ‚悤�`�@–ò•¨Ž¡—ÂƂ̕¹—p
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR�[ƒX�iƒIƒ“ƒfƒ}ƒ“ƒh�j
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
Šâí•�@Œ’‘¾˜Y
“�«—Γà�áŽè�p�@�¬Œ÷—¦‚ð�ã‚°‚é‚É‚Í�H
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
“�«—Γà�áŽè�p�@�¬Œ÷—¦‚ð�ã‚°‚é‚É‚Í�H
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
îà‘º�@‰À�O
“à‰Èˆã–Ú�ü‚Ì“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚̉摜ŒŸ�¸
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
“à‰Èˆã–Ú�ü‚Ì“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚̉摜ŒŸ�¸
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
‘哈�@�G�K�A�‚‘º�@‰À�O
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚ésodium glucose co-transporter 2‘jŠQ–ò‚̉e‹¿
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€4
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚ésodium glucose co-transporter 2‘jŠQ–ò‚̉e‹¿
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï�@ƒVƒ“ƒ|ƒWƒEƒ€4
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
�¼‘º�@Œ’‘å
Šp–ŒˆÚ�A‚ÌŠî–{�@Šp–ŒˆÚ�A‚Ì�pŒãŠÇ—�
‘æ49‰ñ“ú–{Šá‰ÈŽè�pŠw‰ïŠw�p‘�‰ï�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N1ŒŽ30“ú-2ŒŽ1“ú�@•Ÿ‰ª�‘�Û‰ï‹c�ê�Aƒ}ƒŠƒ“ƒ�ƒbƒZ•Ÿ‰ªBŠÙ
Šp–ŒˆÚ�A‚ÌŠî–{�@Šp–ŒˆÚ�A‚Ì�pŒãŠÇ—�
‘æ49‰ñ“ú–{Šá‰ÈŽè�pŠw‰ïŠw�p‘�‰ï�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N1ŒŽ30“ú-2ŒŽ1“ú�@•Ÿ‰ª�‘�Û‰ï‹c�ê�Aƒ}ƒŠƒ“ƒ�ƒbƒZ•Ÿ‰ªBŠÙ
îà‘º�@‰À�O
“œ”A•a–Ô–Œ�Ç�f—ÂÌ�i‰»‚ÆŠá‰È˜AŒg‚Ì�[‰»
‘æ60‰ñ“œ”A•aŠw‚Ì�i•à�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N3ŒŽ27-28“ú�@ŠâŽèŒ§�·‰ªŽs
“œ”A•a–Ô–Œ�Ç�f—ÂÌ�i‰»‚ÆŠá‰È˜AŒg‚Ì�[‰»
‘æ60‰ñ“œ”A•aŠw‚Ì�i•à�@‹³ˆçƒZƒ~ƒi�[
—ߘa8”N3ŒŽ27-28“ú�@ŠâŽèŒ§�·‰ªŽs
ˆî’J�@‘å
ƒŠƒAƒ‹ƒ��[ƒ‹ƒhƒf�[ƒ^‚©‚瓾‚ç‚ꂽiStent inject W‚Ì’·ŠúˆÀ‘S�«‚Æ—LŒø�«
Earlier surgical intervention in glaucoma treatment -—Γà�Ꭱ—Ñ�ŠúŽè�p‰î“ü‚̉”\�«- Vol.2
‘æ129‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@ƒOƒ‰ƒEƒRƒX ƒ‚�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N4ŒŽ17-20“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ƒŠƒAƒ‹ƒ��[ƒ‹ƒhƒf�[ƒ^‚©‚瓾‚ç‚ꂽiStent inject W‚Ì’·ŠúˆÀ‘S�«‚Æ—LŒø�«
Earlier surgical intervention in glaucoma treatment -—Γà�Ꭱ—Ñ�ŠúŽè�p‰î“ü‚̉”\�«- Vol.2
‘æ129‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�@ƒOƒ‰ƒEƒRƒX ƒ‚�[ƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N4ŒŽ17-20“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ˆî’J�@‘å
—Γà�á�pŒã‚Ì”º‘–Žx‰‡
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@‘å’Ë�»–òƒCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
—Γà�á�pŒã‚Ì”º‘–Žx‰‡
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@‘å’Ë�»–òƒCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
ˆî’J�@‘å
—Õ�°Œ¤‹†‚©‚ç‚Ý‚¦‚é�V‚µ‚¢‰Â”\�«
‚±‚ê‚©‚ç‚̗Γà�Ꭱ—Âð�l‚¦‚é〜–ò•¨Ž¡—Â̒m“I�DŠï�S〜
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ŽQ“V�»–òƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
—Õ�°Œ¤‹†‚©‚ç‚Ý‚¦‚é�V‚µ‚¢‰Â”\�«
‚±‚ê‚©‚ç‚̗Γà�Ꭱ—Âð�l‚¦‚é〜–ò•¨Ž¡—Â̒m“I�DŠï�S〜
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ŽQ“V�»–òƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
ˆî’J�@‘å
‘S•ûˆÊŒ^”z�‡“_Šá–òƒOƒ‰ƒAƒ‹ƒtƒ@‚ÌŽg‚¢‚Ç‚±‚ë
Žå—¬�o˜H‚©‚ç‚Ì–[�…—¬�o‚ð�l‚¦‚é
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@‹»˜aДޮ‰ïŽÐƒAƒtƒ^ƒk�[ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
‘S•ûˆÊŒ^”z�‡“_Šá–òƒOƒ‰ƒAƒ‹ƒtƒ@‚ÌŽg‚¢‚Ç‚±‚ë
Žå—¬�o˜H‚©‚ç‚Ì–[�…—¬�o‚ð�l‚¦‚é
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@‹»˜aДޮ‰ïŽÐƒAƒtƒ^ƒk�[ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
ˆî’J�@‘å
’ʉ@Œp‘±—¦‚©‚ç�l‚¦‚é—Γà�Ꭱ—Ã�í—ª
‘�Šú—Γà�á‚ւ̃Aƒvƒ��[ƒ`〜”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“〜Vol.5
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒOƒ‰ƒEƒRƒX�EƒWƒƒƒpƒ“ ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
’ʉ@Œp‘±—¦‚©‚ç�l‚¦‚é—Γà�Ꭱ—Ã�í—ª
‘�Šú—Γà�á‚ւ̃Aƒvƒ��[ƒ`〜”’“à�áŽè�p•¹—pŠá“àƒhƒŒ�[ƒ“〜Vol.5
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒOƒ‰ƒEƒRƒX�EƒWƒƒƒpƒ“ ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
ˆî’J�@‘å
Ž¡—ÑI‘ð�@–ò•¨�HŽè�p�H‚Ç‚¤‘I‚Ô�H
‚¢‚Ü‚³‚ç•·‚¯‚È‚¢—Γà�á2025‚Ç‚¤ƒAƒvƒ��[ƒ`‚·‚é�H�Å“K‚ÈŽ¡—Ã�í—ª‚ւ̃Xƒeƒbƒv
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@�çŽõ�»–òƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
Ž¡—ÑI‘ð�@–ò•¨�HŽè�p�H‚Ç‚¤‘I‚Ô�H
‚¢‚Ü‚³‚ç•·‚¯‚È‚¢—Γà�á2025‚Ç‚¤ƒAƒvƒ��[ƒ`‚·‚é�H�Å“K‚ÈŽ¡—Ã�í—ª‚ւ̃Xƒeƒbƒv
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@�çŽõ�»–òƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
îà‘º�@‰À�O
ƒGƒrƒfƒ“ƒX‚Å‘ñ‚�A�uDME�vгŽÒ‚³‚ñ‚Ì�gŽ‹�h—ˆ
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@�[ƒ}�@ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
ƒGƒrƒfƒ“ƒX‚Å‘ñ‚�A�uDME�vгŽÒ‚³‚ñ‚Ì�gŽ‹�h—ˆ
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@�[ƒ}�@ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi�[
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�EƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
îà‘º�@‰À�O
ƒoƒr�[ƒXƒ‚‚Ì‘�ŠúŽ¡—Éî“ü‚Å‘_‚¤DME“‰»‚̉ñ”ð
‘æ64‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@’†ŠO�»–ò�@ƒCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N12ŒŽ5-7“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
ƒoƒr�[ƒXƒ‚‚Ì‘�ŠúŽ¡—Éî“ü‚Å‘_‚¤DME“‰»‚̉ñ”ð
‘æ64‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�@’†ŠO�»–ò�@ƒCƒuƒjƒ“ƒOƒZƒ~ƒi�[
—ߘa7”N12ŒŽ5-7“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
�™Œ´�@—F‰À
•Ÿˆä‘åŠwˆãŠw•”•�‘®•a‰@‚É‚¨‚¢‚Ä”’�ñ•à�sŒP—û‚ðŽó‚¯‚½Š³ŽÒ‚ÌŽÀ‘Ô’²�¸
‘æ26‰ñ“ú–{ƒ��[ƒrƒWƒ‡ƒ“Šw‰ïŠw�p‘�‰ï�@
—ߘa7”N5ŒŽ23-25“ú�@�L“‡�‘�Û‰ï‹c�ê
•Ÿˆä‘åŠwˆãŠw•”•�‘®•a‰@‚É‚¨‚¢‚Ä”’�ñ•à�sŒP—û‚ðŽó‚¯‚½Š³ŽÒ‚ÌŽÀ‘Ô’²�¸
‘æ26‰ñ“ú–{ƒ��[ƒrƒWƒ‡ƒ“Šw‰ïŠw�p‘�‰ï�@
—ߘa7”N5ŒŽ23-25“ú�@�L“‡�‘�Û‰ï‹c�ê
’Ò�@�ç—z�A’Ò�@—²�G
ƒoƒ‹ƒvƒ�Ž_‘Ù“à“Š—^ƒ}ƒEƒX‚Ö‚ÌŒoŒûƒJƒ‹ƒmƒVƒ““Š—^‚É‚æ‚éŽÐ‰ï�«‰ü‘PŒø‰Ê‚̉ð�Í
‘æ68‰ñ“ú–{�_Œo‰»Šw‰ï‘å‰ï
—ߘa7”N9ŒŽ11-13“ú�@ƒEƒBƒ“ƒN‚ ‚¢‚¿
ƒoƒ‹ƒvƒ�Ž_‘Ù“à“Š—^ƒ}ƒEƒX‚Ö‚ÌŒoŒûƒJƒ‹ƒmƒVƒ““Š—^‚É‚æ‚éŽÐ‰ï�«‰ü‘PŒø‰Ê‚̉ð�Í
‘æ68‰ñ“ú–{�_Œo‰»Šw‰ï‘å‰ï
—ߘa7”N9ŒŽ11-13“ú�@ƒEƒBƒ“ƒN‚ ‚¢‚¿
Inatani M, Tone Y, Ikeda T, Angeles R
Sepetaprost alone and in combination with timolol in a long-term study (ANGEL-J2)
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
Sepetaprost alone and in combination with timolol in a long-term study (ANGEL-J2)
‘æ36‰ñ“ú–{—Γà�áŠw‰ï�@
—ߘa7”N9ŒŽ12-14“ú�@�_ŒËƒ|�[ƒgƒsƒAƒzƒeƒ‹
ˆî’J�@‘å
ƒxƒ“ƒUƒ‹ƒRƒjƒEƒ€”ñŠÜ—L‹y‚ÑŠÜ—LƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá‰t‚Ì”äŠrŽŽŒ±
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
ƒxƒ“ƒUƒ‹ƒRƒjƒEƒ€”ñŠÜ—L‹y‚ÑŠÜ—LƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ��[ƒ‹”z�‡“_Šá‰t‚Ì”äŠrŽŽŒ±
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
îà‘º‰À�O�AYongsoo Kim
‘��B“œ”A•a–Ô–Œ�ǂɑ΂·‚éƒuƒ�ƒ‹ƒVƒYƒ}ƒ‹�FCONDORŽŽŒ±54�T‚Ì“ú–{�lƒTƒuƒOƒ‹�[ƒv‰ð�Í
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
‘��B“œ”A•a–Ô–Œ�ǂɑ΂·‚éƒuƒ�ƒ‹ƒVƒYƒ}ƒ‹�FCONDORŽŽŒ±54�T‚Ì“ú–{�lƒTƒuƒOƒ‹�[ƒv‰ð�Í
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
—L‘º�@�®Œå
�l�H’m”\‚ª’�–Ú‚·‚éŠá’ê�\‘¢‚ÉŠî‚—Γà�á‚Ì�V‚½‚ÈŽ‹Šo“I‰ðŽß
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
�l�H’m”\‚ª’�–Ú‚·‚éŠá’ê�\‘¢‚ÉŠî‚—Γà�á‚Ì�V‚½‚ÈŽ‹Šo“I‰ðŽß
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
Šâ핌’‘¾˜Y�A—L‘º�®Œå�A�‚‘º‰À�O�Aˆî’J‘å
—Γà�áŽè�pšn�D’²�¸2024
Clinical Practice Preferences for Glaucoma Surgery in Japan in 2024
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
—Γà�áŽè�pšn�D’²�¸2024
Clinical Practice Preferences for Glaucoma Surgery in Japan in 2024
‘æ79‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï
—ߘa7”N10ŒŽ9-12“ú�@‘å�ã�‘�Û‰ï‹c�ê�AƒŠ�[ƒKƒ�ƒCƒ„ƒ‹ƒzƒeƒ‹‘å�ã
’Ò—²�G�Aˆî’J‘å
‰ß‹Ž13”NŠÔ‚É•Ÿˆä‘åŠwŠá‰È‚ÅŒoŒ±‚µ‚½•@�«Ž‹�_Œo�Ç11—á‚ÌŒŸ“¢
‘æ63‰ñ“ú–{�_ŒoŠá‰ÈŠw‰ï‘�‰ï
—ߘa7”N11ŒŽ21-22“ú�@�ç—¢ƒ‰ƒCƒtƒTƒCƒGƒ“ƒXƒZƒ“ƒ^�[
‰ß‹Ž13”NŠÔ‚É•Ÿˆä‘åŠwŠá‰È‚ÅŒoŒ±‚µ‚½•@�«Ž‹�_Œo�Ç11—á‚ÌŒŸ“¢
‘æ63‰ñ“ú–{�_ŒoŠá‰ÈŠw‰ï‘�‰ï
—ߘa7”N11ŒŽ21-22“ú�@�ç—¢ƒ‰ƒCƒtƒTƒCƒGƒ“ƒXƒZƒ“ƒ^�[
ŽR“c—Y‹M�AáÁ“c˜Ð‹G�A�‚‘º‰À�O�A‘哈�G�K�AŒã‘ò�½�Aˆî’J‘å
‹Ç�Š�«“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é’¼�ڋÌłÆFaricimab“Š—^‚Ì�‡�˜‚Ì—DˆÊ�«
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
‹Ç�Š�«“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é’¼�ڋÌłÆFaricimab“Š—^‚Ì�‡�˜‚Ì—DˆÊ�«
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
áÁ“c˜Ð‹G�A�‚‘º‰À�O�AŽR“c—Y‹M�A�¡–ìˆÇ”ü�A•½–ì—²—Y�A–ì�è”ü•ä�Aˆî’J‘å
�RVEGF–òŽ¡—ÃŒã‚É’¾�É»‚µ‚½“œ”A•a‰©”Á•‚Žî‚É‚¨‚¯‚é–³ŒŒŠÇ—Ìˆæ‚ÆŽ‹–슴“x‚Æ‚Ì‘ŠŠÖ
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
�RVEGF–òŽ¡—ÃŒã‚É’¾�É»‚µ‚½“œ”A•a‰©”Á•‚Žî‚É‚¨‚¯‚é–³ŒŒŠÇ—Ìˆæ‚ÆŽ‹–슴“x‚Æ‚Ì‘ŠŠÖ
‘æ32‰ñ“ú–{“œ”A•aŠáŠw‰ï‘�‰ï
—ߘa8”N1ŒŽ16-17“ú�@ƒpƒVƒtƒBƒR‰¡•l
�™Œ´�@—F‰À
Žq‚Ç‚à‚½‚¿‚Ì–Ú‚ðŽç‚邽‚ß‚É
‘æ76‰ñ•ŸˆäŒ§�¬Ž™•ÛŒ’‹¦‰ïŠw�p�W‰ï
—ߘa8”N2ŒŽ11“ú�@�@•ŸˆäŽs
Žq‚Ç‚à‚½‚¿‚Ì–Ú‚ðŽç‚邽‚ß‚É
‘æ76‰ñ•ŸˆäŒ§�¬Ž™•ÛŒ’‹¦‰ïŠw�p�W‰ï
—ߘa8”N2ŒŽ11“ú�@�@•ŸˆäŽs
�‚‘º�@‰À�O
“œ”A•a‚ÅŽ¸–¾‚µ‚È‚¢‚悤‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
Šá‰È�~“œ”A•a�f—Èã�@˜AŒg‚̉ï in TOYOTA
—ߘa7”N6ŒŽ4“ú�@ˆ¤’mŒ§–L“cŽs
“œ”A•a‚ÅŽ¸–¾‚µ‚È‚¢‚悤‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
Šá‰È�~“œ”A•a�f—Èã�@˜AŒg‚̉ï in TOYOTA
—ߘa7”N6ŒŽ4“ú�@ˆ¤’mŒ§–L“cŽs
ˆî’J�@‘å
�[‘wŠw�Kƒ‚ƒfƒ‹‚ŗΓà�á“_ŠáŽ¡—Âð•ª�Í‚·‚é�B
Mikeluna WEEK 2025�`—Γà�Ꭱ—Âð�l‚¦‚é�`
—ߘa7”N6ŒŽ11“ú�@•ŸˆäŽs‚©‚ç‘S�‘WEB”z�M
�[‘wŠw�Kƒ‚ƒfƒ‹‚ŗΓà�á“_ŠáŽ¡—Âð•ª�Í‚·‚é�B
Mikeluna WEEK 2025�`—Γà�Ꭱ—Âð�l‚¦‚é�`
—ߘa7”N6ŒŽ11“ú�@•ŸˆäŽs‚©‚ç‘S�‘WEB”z�M
�‚‘º�@‰À�O
“�«DME‚ɑ΂·‚éƒtƒ@ƒŠƒVƒ}ƒu‚Ö‚ÌŠú‘Ò
–Ô–ŒŽ¾Š³‚Ì�fŽ@‚ð�l‚¦‚é‰ï�`Ang-2‘jŠQˆÓ‹`‚É—§‚¿•Ô‚é�`
—ߘa7”N6ŒŽ16“ú�@‘å�ãŽs
“�«DME‚ɑ΂·‚éƒtƒ@ƒŠƒVƒ}ƒu‚Ö‚ÌŠú‘Ò
–Ô–ŒŽ¾Š³‚Ì�fŽ@‚ð�l‚¦‚é‰ï�`Ang-2‘jŠQˆÓ‹`‚É—§‚¿•Ô‚é�`
—ߘa7”N6ŒŽ16“ú�@‘å�ãŽs
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
AILAMIDE 5th Anniversary SENJU Live Web Sminar
—ߘa7”N7ŒŽ2“ú�@•ŸˆäŽs‚©‚ç’†Žl�‘‚ÖWeb”z�M
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
AILAMIDE 5th Anniversary SENJU Live Web Sminar
—ߘa7”N7ŒŽ2“ú�@•ŸˆäŽs‚©‚ç’†Žl�‘‚ÖWeb”z�M
’Ò�@—²�G�@�@
•Ÿˆä‘åŠwŠá‰È‚ł̎‹�_Œo޾г�f—Âɂ‚¢‚Ä
•ŸˆäŒ§Šá‰È�E”]�_Œo“à‰È�‡“¯ƒZƒ~ƒi�[
—ߘa7”N7ŒŽ17“ú�@•ŸˆäŽs
•Ÿˆä‘åŠwŠá‰È‚ł̎‹�_Œo޾г�f—Âɂ‚¢‚Ä
•ŸˆäŒ§Šá‰È�E”]�_Œo“à‰È�‡“¯ƒZƒ~ƒi�[
—ߘa7”N7ŒŽ17“ú�@•ŸˆäŽs
ˆî’J�@‘å
—Γà�áŽè�pŽ¡—à Up to date
—Γà�áŽè�p‚ð�l‚¦‚é‰ïin“Þ—Ç
—ߘa7”N7ŒŽ24“ú�@“Þ—ÇŽs
—Γà�áŽè�pŽ¡—à Up to date
—Γà�áŽè�p‚ð�l‚¦‚é‰ïin“Þ—Ç
—ߘa7”N7ŒŽ24“ú�@“Þ—ÇŽs
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
‘æ27‰ñ‰«“êŠá޾гƒtƒH�[ƒ‰ƒ€
—ߘa7”N7ŒŽ26“ú�@‰«“ꌧ“ß”eŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
‘æ27‰ñ‰«“êŠá޾гƒtƒH�[ƒ‰ƒ€
—ߘa7”N7ŒŽ26“ú�@‰«“ꌧ“ß”eŽs
�‚‘º�@‰À�O
“œ”A•a‚ÅŽ¸–¾‚³‚¹‚È‚¢‚½‚ß‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
•ŸˆäŒ§“à‰Èˆã‰ïŠw�p�u‰‰‰ï
—ߘa7”N8ŒŽ2“ú�@•ŸˆäŒ§ˆãŽt‰ïŠÙ
“œ”A•a‚ÅŽ¸–¾‚³‚¹‚È‚¢‚½‚ß‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
•ŸˆäŒ§“à‰Èˆã‰ïŠw�p�u‰‰‰ï
—ߘa7”N8ŒŽ2“ú�@•ŸˆäŒ§ˆãŽt‰ïŠÙ
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
‘æ43‰ñ“¹–kŠá‰Èˆã‰ï�W’k‰ï
—ߘa7”N8ŒŽ23“ú�@–kŠC“¹ˆ®�ìŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
‘æ43‰ñ“¹–kŠá‰Èˆã‰ï�W’k‰ï
—ߘa7”N8ŒŽ23“ú�@–kŠC“¹ˆ®�ìŽs
îà‘º�@‰À�O
“�«DME‚ɑ΂·‚éƒoƒr�[ƒXƒ‚‚Ö‚ÌŠú‘Ò
ƒoƒr�[ƒXƒ‚””„3Žü”N‹L”O�u‰‰‰ï in –k‹ã�B
—ߘa7”N8ŒŽ28“ú�@•Ÿ‰ªŒ§
“�«DME‚ɑ΂·‚éƒoƒr�[ƒXƒ‚‚Ö‚ÌŠú‘Ò
ƒoƒr�[ƒXƒ‚””„3Žü”N‹L”O�u‰‰‰ï in –k‹ã�B
—ߘa7”N8ŒŽ28“ú�@•Ÿ‰ªŒ§
îà‘º�@‰À�O
ƒoƒr�[ƒXƒ‚‚Ì“Á�«‚ð�¶‚©‚µ‚½DMEŽ¡—Ã
HOT TOPICS Web seminar on ophthalmology
—ߘa7”N8ŒŽ29“ú�@‘å�ãŽs‚©‚çWeb”z�M
ƒoƒr�[ƒXƒ‚‚Ì“Á�«‚ð�¶‚©‚µ‚½DMEŽ¡—Ã
HOT TOPICS Web seminar on ophthalmology
—ߘa7”N8ŒŽ29“ú�@‘å�ãŽs‚©‚çWeb”z�M
îà‘º�@‰À�O
гŽÒƒtƒ@�[ƒXƒg‚ÌDMEŽ¡—Ã
Tokyo-bay Ophthalmic Seminar ~The Next Generations~
—ߘa7”N9ŒŽ3“ú�@�ç—tŒ§‰YˆÀŽs
гŽÒƒtƒ@�[ƒXƒg‚ÌDMEŽ¡—Ã
Tokyo-bay Ophthalmic Seminar ~The Next Generations~
—ߘa7”N9ŒŽ3“ú�@�ç—tŒ§‰YˆÀŽs
îà‘º�@‰À�O
ƒxƒIƒrƒ…‚ª’˜Œø‚·‚éDME�Ç—á‚Ì“Á’¥‚ð�l‚¦‚é
DMEŽ¡—Â̗Õ�°’m�`•a�¨‚ðŒ©‹É‚ß�AŽ‹—Í‚ðŽç‚é�`
—ߘa7”N9ŒŽ8“ú�@Web”z�M
ƒxƒIƒrƒ…‚ª’˜Œø‚·‚éDME�Ç—á‚Ì“Á’¥‚ð�l‚¦‚é
DMEŽ¡—Â̗Õ�°’m�`•a�¨‚ðŒ©‹É‚ß�AŽ‹—Í‚ðŽç‚é�`
—ߘa7”N9ŒŽ8“ú�@Web”z�M
îà‘º�@‰À�O
“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚ɑ΂·‚éSTTA Žè‹Z
‚í‚©‚à‚Æ�»–òWeb�u‰‰‰ï
—ߘa7”N9ŒŽ19“ú�@Web”z�M
“œ”A•a–Ô–Œ�Ç�E‰©”Á•‚Žî‚ɑ΂·‚éSTTA Žè‹Z
‚í‚©‚à‚Æ�»–òWeb�u‰‰‰ï
—ߘa7”N9ŒŽ19“ú�@Web”z�M
îà‘º�@‰À�O
Œ¤‹†‚ðŠy‚µ‚ñ‚ł݂܂¹‚ñ‚©�H�`Ž„‚Ì•à‚ñ‚¾“œ”A•aŠá�‡•¹�ǂ̌¤‹†�`
‘æ107‰ñ“Œ‹žˆã‘åŠá‰È—Õ�°�§˜b‰ï
—ߘa7”N10ŒŽ4“ú�@“Œ‹ž“s
Œ¤‹†‚ðŠy‚µ‚ñ‚ł݂܂¹‚ñ‚©�H�`Ž„‚Ì•à‚ñ‚¾“œ”A•aŠá�‡•¹�ǂ̌¤‹†�`
‘æ107‰ñ“Œ‹žˆã‘åŠá‰È—Õ�°�§˜b‰ï
—ߘa7”N10ŒŽ4“ú�@“Œ‹ž“s
ˆî’J�@‘å
‚܂Ƃ߂ĉð�à�I—Γà�á“_Šá–ò2025
‘æ4‰ñ International Airport Ophthalmic Seminar
—ߘa7”N10ŒŽ25“ú�@�ç—tŒ§�¬“cŽs
‚܂Ƃ߂ĉð�à�I—Γà�á“_Šá–ò2025
‘æ4‰ñ International Airport Ophthalmic Seminar
—ߘa7”N10ŒŽ25“ú�@�ç—tŒ§�¬“cŽs
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
�é‹ÊŒ§Šá‰È‹³ˆç�u‰‰‰ï
—ߘa7”N10ŒŽ26“ú�@�é‹ÊŒ§‚³‚¢‚½‚ÜŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
�é‹ÊŒ§Šá‰È‹³ˆç�u‰‰‰ï
—ߘa7”N10ŒŽ26“ú�@�é‹ÊŒ§‚³‚¢‚½‚ÜŽs
îà‘º�@‰À�O
гŽÒƒtƒ@�[ƒXƒg‚ð”O“ª‚É“ü‚ꂽ“œ”A•aŠá�‡•¹�ǂɑ΂·‚é�ŗǂ̎¡—Ã�í—ª‚ð‚ß‚´‚µ‚Ä
–L’†ŽsˆãŽt‰ïŠá‰Èˆã‰ïŠw�pŒ¤‹†‰ï
—ߘa7”N11ŒŽ1“ú�@‘å�ã•{–L’†Žs
гŽÒƒtƒ@�[ƒXƒg‚ð”O“ª‚É“ü‚ꂽ“œ”A•aŠá�‡•¹�ǂɑ΂·‚é�ŗǂ̎¡—Ã�í—ª‚ð‚ß‚´‚µ‚Ä
–L’†ŽsˆãŽt‰ïŠá‰Èˆã‰ïŠw�pŒ¤‹†‰ï
—ߘa7”N11ŒŽ1“ú�@‘å�ã•{–L’†Žs
ˆî’J�@‘å
—Γà�áŽè�pŽ¡—Ãup to date 2025
ROCKƒJƒ“ƒtƒ@ƒŒƒ“ƒX in Ž ‰ê
—ߘa7”N11ŒŽ6“ú�@Ž ‰êŒ§‘å’ÃŽs
—Γà�áŽè�pŽ¡—Ãup to date 2025
ROCKƒJƒ“ƒtƒ@ƒŒƒ“ƒX in Ž ‰ê
—ߘa7”N11ŒŽ6“ú�@Ž ‰êŒ§‘å’ÃŽs
ˆî’J�@‘å
—Γà�á‚Ì–ò•¨Ž¡—Ã�@‚Ç‚¤‘±‚¯‚é�H
ƒAƒCƒ‰ƒ~ƒh”z�‡Œœ‘÷�«“_Šá‰t�@””„5Žü”N‹L”OƒZƒ~ƒi�[
‘æ3‰ñ�@‰ð�à�I—Γà�Ꭱ—ẪRƒc‚ƃ|ƒCƒ“ƒg
—ߘa7”N11ŒŽ7“ú�@•ŸˆäŽs‚©‚ç‘S�‘Web”z�M
—Γà�á‚Ì–ò•¨Ž¡—Ã�@‚Ç‚¤‘±‚¯‚é�H
ƒAƒCƒ‰ƒ~ƒh”z�‡Œœ‘÷�«“_Šá‰t�@””„5Žü”N‹L”OƒZƒ~ƒi�[
‘æ3‰ñ�@‰ð�à�I—Γà�Ꭱ—ẪRƒc‚ƃ|ƒCƒ“ƒg
—ߘa7”N11ŒŽ7“ú�@•ŸˆäŽs‚©‚ç‘S�‘Web”z�M
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
‘æ23‰ñŒ§“òŠá‰È—Õ�°ƒtƒH�[ƒ‰ƒ€
—ߘa7”N11ŒŽ8“ú�@•ºŒÉŒ§“ò�èŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�á“_Šá–ò2025
‘æ23‰ñŒ§“òŠá‰È—Õ�°ƒtƒH�[ƒ‰ƒ€
—ߘa7”N11ŒŽ8“ú�@•ºŒÉŒ§“ò�èŽs
îà‘º�@‰À�O
DMEŽ¡—ÂÉ�¶‚©‚¹‚éƒoƒr�[ƒXƒ‚‚Ì“Á�«‚ð�l‚¦‚é
“œ”A•a‚ð�l‚¦‚é‰ï in ˆï�é�@�`Šá‰È�~“œ”A•a“à‰È�`
—ߘa7”N11ŒŽ10“ú�@ˆï�錧“y‰YŽs
DMEŽ¡—ÂÉ�¶‚©‚¹‚éƒoƒr�[ƒXƒ‚‚Ì“Á�«‚ð�l‚¦‚é
“œ”A•a‚ð�l‚¦‚é‰ï in ˆï�é�@�`Šá‰È�~“œ”A•a“à‰È�`
—ߘa7”N11ŒŽ10“ú�@ˆï�錧“y‰YŽs
ˆî’J�@‘å
—Õ�°�¬�Ñ‚©‚ç‚Ý‚½�V‚µ‚¢‰Â”\�«
—Γà�Ꭱ—ÂÌ�V�Í�|ƒZƒ^ƒlƒI®“_Šá‰t0.002%‚Ì“o�ê�\
—ߘa7”N11ŒŽ10“ú�@•ŸˆäŽs‚©‚ç‘S�‘Web”z�M
—Õ�°�¬�Ñ‚©‚ç‚Ý‚½�V‚µ‚¢‰Â”\�«
—Γà�Ꭱ—ÂÌ�V�Í�|ƒZƒ^ƒlƒI®“_Šá‰t0.002%‚Ì“o�ê�\
—ߘa7”N11ŒŽ10“ú�@•ŸˆäŽs‚©‚ç‘S�‘Web”z�M
îà‘º�@‰À�O
“œ”A•a‚ÅŽ¸–¾‚µ‚È‚¢‚悤‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
‘æ6‰ñ�@Ozone Ophthalmology Seminar
—ߘa7”N11ŒŽ27“ú�@ˆ¤’mŒ§‚©‚çWeb”z�M
“œ”A•a‚ÅŽ¸–¾‚µ‚È‚¢‚悤‚É�`‹�‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg�`
‘æ6‰ñ�@Ozone Ophthalmology Seminar
—ߘa7”N11ŒŽ27“ú�@ˆ¤’mŒ§‚©‚çWeb”z�M
ˆî’J�@‘å
‘æ“ñ‘I‘ð–ò‚Æ‚µ‚Ă̔z�‡�Ü‚ð�l‚¦‚é�`‘S•ûˆÊŒ^”z�‡“_Šá–òƒOƒ‰ƒAƒ‹ƒtƒ@‚ÌŽg‚¢‚Ç‚±‚ë�`
Glaucoma Treatment OptionsƒZƒ~ƒi�[
—ߘa7”N12ŒŽ5“ú�@“Œ‹ž“s‚©‚ç‘S�‘Web”z�M
‘æ“ñ‘I‘ð–ò‚Æ‚µ‚Ă̔z�‡�Ü‚ð�l‚¦‚é�`‘S•ûˆÊŒ^”z�‡“_Šá–òƒOƒ‰ƒAƒ‹ƒtƒ@‚ÌŽg‚¢‚Ç‚±‚ë�`
Glaucoma Treatment OptionsƒZƒ~ƒi�[
—ߘa7”N12ŒŽ5“ú�@“Œ‹ž“s‚©‚ç‘S�‘Web”z�M
ˆî’J�@‘å
—Γà�áŽè�pŽ¡—Ãup to date
KOWA Ophthalmology Academy
—ߘa7”N12ŒŽ12“ú�@“È–ØŒ§‰F“s‹{Žs
—Γà�áŽè�pŽ¡—Ãup to date
KOWA Ophthalmology Academy
—ߘa7”N12ŒŽ12“ú�@“È–ØŒ§‰F“s‹{Žs
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
‘æ119‰ñ�H“cŒ§Šá‰È�W’k‰ï
—ߘa7”N12ŒŽ14“ú�@�H“cŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2025
‘æ119‰ñ�H“cŒ§Šá‰È�W’k‰ï
—ߘa7”N12ŒŽ14“ú�@�H“cŽs
ˆî’J�@‘å
‚܂Ƃ߂ĉð�à�I—Γà�á“_Šá–ò2026
‘æ5‰ñGR‚̉ï
—ߘa8”N2ŒŽ14“ú�@ŽRŒûŒ§Žü“ìŽs
‚܂Ƃ߂ĉð�à�I—Γà�á“_Šá–ò2026
‘æ5‰ñGR‚̉ï
—ߘa8”N2ŒŽ14“ú�@ŽRŒûŒ§Žü“ìŽs
ˆî’J�@‘å
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2026
Šò•ŒŒ§Šá‰Èˆã‰ï�¶ŠU‹³ˆç�u�K‰ï
—ߘa8”N2ŒŽ15“ú�@Šò•ŒŽs
[‚ä‚Á‚‚è‰ð�à]—Γà�áŽè�pŽ¡—Ã2026
Šò•ŒŒ§Šá‰Èˆã‰ï�¶ŠU‹³ˆç�u�K‰ï
—ߘa8”N2ŒŽ15“ú�@Šò•ŒŽs
îà‘º�@‰À�O
DMEŽ¡—ÂÉ�¶‚©‚¹‚éƒoƒr�[ƒXƒ‚‚Ì“Á�«
DME Expert Web Seminar
—ߘa8”N2ŒŽ18“ú�@Web”z�M
DMEŽ¡—ÂÉ�¶‚©‚¹‚éƒoƒr�[ƒXƒ‚‚Ì“Á�«
DME Expert Web Seminar
—ߘa8”N2ŒŽ18“ú�@Web”z�M
ˆî’J�@‘å
‘±”—Γà�á‚ÌŽè�p‚Í‚±‚¤‚·‚é‚ñ‚¾�I
‘æ20‰ñ‹ž‘åŠá‰È�@Focus on Glaucoma
—ߘa8”N3ŒŽ6“ú�@•ŸˆäŽs‚©‚狞“sŽs‚ÖWeb”z�M
‘±”—Γà�á‚ÌŽè�p‚Í‚±‚¤‚·‚é‚ñ‚¾�I
‘æ20‰ñ‹ž‘åŠá‰È�@Focus on Glaucoma
—ߘa8”N3ŒŽ6“ú�@•ŸˆäŽs‚©‚狞“sŽs‚ÖWeb”z�M
ˆî’J�@‘å
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2026
‘æ10‰ñ‚ЂƂ݃lƒbƒg‚̉ï
—ߘa8”N3ŒŽ21“ú�@–¼ŒÃ‰®Žs
�y‚ä‚Á‚‚è‰ð�à�z—Γà�á“_Šá–ò2026
‘æ10‰ñ‚ЂƂ݃lƒbƒg‚̉ï
—ߘa8”N3ŒŽ21“ú�@–¼ŒÃ‰®Žs
—F“c�Ê�…�AŠâ핌’‘¾˜Y�Aˆî’J‘å
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚é—Γà�áŽè�p‚ÌŽ¡—Ã�¬�Ñ
‘æ354‰ñ‹à‘òŠá‰È�W’k‰ï�@
—ߘa7”N4ŒŽ6“ú�@‹à‘òŽs
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚é—Γà�áŽè�p‚ÌŽ¡—Ã�¬�Ñ
‘æ354‰ñ‹à‘òŠá‰È�W’k‰ï�@
—ߘa7”N4ŒŽ6“ú�@‹à‘òŽs
îà‘º‰À�O�AáÁ“c˜Ð‹G�AŽR“c—Y‹M�Aˆî’J‘å
‹Ç�Š�«DME‚ɑ΂·‚é’¼�ÚƒŒ�[ƒU�[‚Ì‘O‚É‚Í�RVEGFŽ¡—·‚é‚ׂ«‚©�H
‘æ5‰ñ’á�N�P–Ô–ŒƒŒ�[ƒU�[‚̉ï
—ߘa7”N4ŒŽ17“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
‹Ç�Š�«DME‚ɑ΂·‚é’¼�ÚƒŒ�[ƒU�[‚Ì‘O‚É‚Í�RVEGFŽ¡—·‚é‚ׂ«‚©�H
‘æ5‰ñ’á�N�P–Ô–ŒƒŒ�[ƒU�[‚̉ï
—ߘa7”N4ŒŽ17“ú�@“Œ‹ž�‘�ÛƒtƒH�[ƒ‰ƒ€
‘哈�G�K
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGF—Ö@ŠJŽnŒã‚ÌŒŒ“œƒRƒ“ƒgƒ��[ƒ‹
‘æ9‰ñ–k—¤4‘åŠwŠá‰È�‡“¯Œ¤‹†‰ï
—ߘa7”N5ŒŽ30“ú�@‹à‘òŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�RVEGF—Ö@ŠJŽnŒã‚ÌŒŒ“œƒRƒ“ƒgƒ��[ƒ‹
‘æ9‰ñ–k—¤4‘åŠwŠá‰È�‡“¯Œ¤‹†‰ï
—ߘa7”N5ŒŽ30“ú�@‹à‘òŽs
�Ÿ”ö�Ê�…�AŠâ핌’‘¾˜Y�Aˆî’J‘å
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚éƒoƒ‹ƒxƒ‹ƒg‚ƃA�[ƒ�ƒh‚ÌŽè�p�¬�Ñ”äŠr
‘æ91‰ñ•xŽRŠá‰È�W’k‰ï
—ߘa7”N6ŒŽ29“ú�@•xŽRŽs
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚éƒoƒ‹ƒxƒ‹ƒg‚ƃA�[ƒ�ƒh‚ÌŽè�p�¬�Ñ”äŠr
‘æ91‰ñ•xŽRŠá‰È�W’k‰ï
—ߘa7”N6ŒŽ29“ú�@•xŽRŽs
�¼‘ºŒ’‘å
—Γà�á”z�‡“_Šá‰t“_ŠáŒã‚É‚¨‚¯‚éŠá‹…‚ÌŒõŠw“IŽ¿‚Ì•]‰¿�F–³�ìˆ×‰»“ñ�dŽÕ•ÁƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
‘æ10‰ñ AGTS‚̉ï
—ߘa7”N7ŒŽ4-5“ú�@�å‘äŽs
—Γà�á”z�‡“_Šá‰t“_ŠáŒã‚É‚¨‚¯‚éŠá‹…‚ÌŒõŠw“IŽ¿‚Ì•]‰¿�F–³�ìˆ×‰»“ñ�dŽÕ•ÁƒNƒ�ƒXƒI�[ƒo�[ŽŽŒ±
‘æ10‰ñ AGTS‚̉ï
—ߘa7”N7ŒŽ4-5“ú�@�å‘äŽs
—é–Ø—z•½�AŽR“c—Y‹M�A�‚‘º‰À�O�Aˆî’J‘å
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éƒtƒ@ƒŠƒVƒ}ƒu“Š—^Œã‚ÌŽc‘¶•‚Žî‚É‚¨‚¯‚é–Ñ�׌ŒŠÇᎂ̉ð�Í
‘æ81‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï
—ߘa7”N8ŒŽ30“ú�@•ŸˆäŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éƒtƒ@ƒŠƒVƒ}ƒu“Š—^Œã‚ÌŽc‘¶•‚Žî‚É‚¨‚¯‚é–Ñ�׌ŒŠÇᎂ̉ð�Í
‘æ81‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï
—ߘa7”N8ŒŽ30“ú�@•ŸˆäŽs
�Ÿ”ö�Ê�…�AŠâ핌’‘¾˜Y�Aˆî’J‘å
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚éƒoƒ‹ƒxƒ‹ƒg‚ƃA�[ƒ�ƒh‚ÌŽè�p�¬�Ñ”äŠr
‘æ45‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï
—ߘa7”N11ŒŽ9“ú�@‹à‘òŽs
ŒŒŠÇ�V�¶—Γà�á‚ɑ΂·‚éƒoƒ‹ƒxƒ‹ƒg‚ƃA�[ƒ�ƒh‚ÌŽè�p�¬�Ñ”äŠr
‘æ45‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï
—ߘa7”N11ŒŽ9“ú�@‹à‘òŽs
”ª“c�@‘ñ–ç
CO‚É‚æ‚镟ˆä‘åŠw‚̃��[ƒrƒWƒ‡ƒ“ƒPƒA‚ÌŽæ‚è‘g‚Ý
•ŸˆäŒ§ƒ��[ƒrƒWƒ‡ƒ“ƒPƒAƒZƒ~ƒi�[
—ߘa7”N11ŒŽ28“ú�@•ŸˆäŽs
CO‚É‚æ‚镟ˆä‘åŠw‚̃��[ƒrƒWƒ‡ƒ“ƒPƒA‚ÌŽæ‚è‘g‚Ý
•ŸˆäŒ§ƒ��[ƒrƒWƒ‡ƒ“ƒPƒAƒZƒ~ƒi�[
—ߘa7”N11ŒŽ28“ú�@•ŸˆäŽs
“cŒû—D‘¾�AŽR“c—Y‹M�A�‚‘º‰À�O�Aˆî’J‘å�AJ-CREST group
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�ÉŽq‘ÌŽè�p‚Ì—LŒø�«‚ÉŠÖ‚·‚鑽Ž{�Ý•]‰¿
‘æ92‰ñ•xŽRŠá‰È�W’k‰ï�@
—ߘa7”N11ŒŽ30“ú�@•xŽRŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�ÉŽq‘ÌŽè�p‚Ì—LŒø�«‚ÉŠÖ‚·‚鑽Ž{�Ý•]‰¿
‘æ92‰ñ•xŽRŠá‰È�W’k‰ï�@
—ߘa7”N11ŒŽ30“ú�@•xŽRŽs
“cŒû—D‘¾�AŽR“c—Y‹M�A�‚‘º‰À�O�Aˆî’J‘å�AJ-CREST group
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�ÉŽq‘ÌŽè�p‚Ì—LŒø�«‚ÉŠÖ‚·‚鑽Ž{�Ý•]‰¿
‘æ355‰ñ‹à‘òŠá‰È�W’k‰ï�@
—ߘa7”N12ŒŽ14“ú�@‹à‘òŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚é�ÉŽq‘ÌŽè�p‚Ì—LŒø�«‚ÉŠÖ‚·‚鑽Ž{�Ý•]‰¿
‘æ355‰ñ‹à‘òŠá‰È�W’k‰ï�@
—ߘa7”N12ŒŽ14“ú�@‹à‘òŽs
“cŒû—D‘¾
�ÉŽq‘Ì“à’�ŽË‚Ç‚¤‚µ‚Ä‚é�H
‘æ82‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï
—ߘa8”N1ŒŽ10“ú�@ƒzƒeƒ‹ƒtƒWƒ^•Ÿˆä
�ÉŽq‘Ì“à’�ŽË‚Ç‚¤‚µ‚Ä‚é�H
‘æ82‰ñ•ŸˆäŒ§Šá‰È�W’k‰ï
—ߘa8”N1ŒŽ10“ú�@ƒzƒeƒ‹ƒtƒWƒ^•Ÿˆä
‰ß‹Ž‚Ì‹Æ�Ñ
Šw‰ï”•\�@2025
Šw‰ï”•\�@2024
Šw‰ï”•\�@2023
Šw‰ï”•\�@2022
Šw‰ï”•\�@2021
Šw‰ï”•\�@2020
Šw‰ï”•\�@2019
Šw‰ï”•\�@2018
Šw‰ï”•\�@2017
Šw‰ï”•\�@2016
Šw‰ï”•\�@2015
Šw‰ï”•\�@2014
Šw‰ï”•\�@2013
Šw‰ï”•\�@2012





![“ü‹Ç‚ðŠó–]‚·‚éŠF—l‚Ö](../../images/global_05.png)

